Trial Profile
A phase III trial to determine the efficacy and safety of Egalet 001 an abuse-deterrent, extended-release, oral morphine product in individuals with chronic low back pain
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Jul 2019
Price :
$35
*
At a glance
- Drugs Morphine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Zyla Life Sciences
- 29 Sep 2014 New trial record